5-Amino-1MQ Peptide Therapy Procedure 1
Here is what the evidence supports, what might help, and what is a waste of time
GLP-1 medications work by: Slowing gastric emptying, which keeps you feeling full for longer Increasing insulin production from the pancreas and increasing insulin sensitivity in various tissues in the body Reducing appetite by acting on hunger centers in the brain Suppressing glucagon, a hormone that raises blood sugar To support informed decision-making, its also worth distinguishing between the current FDA-approved uses of GLP-1 meds and off-label applications
A separate analysis done at Virginia Commonwealth University of more than 841,000 patients with stage 1, 2, or 3 breast cancer, also showed that at five and 10 years after treatment, the women who had been taking GLP-1 drugs had a stunning 60% lower death rate from any cause compared to non-GLP-1 users
BPC-157 is a synthetic fragment derived from a gastric protein